Back to top
more

First Trust NASDAQ Pharmaceuticals ETF: (FTXH)

(Delayed Data from NASDAQ) As of May 17, 2021 12:32 PM ET

 Add to portfolio

$26.13 USD

26.1287
1,122

+0.13 (0.49%)

Volume: 1,122

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

3 - Hold of 5     3    

ETF Quote Details

Previous Close 26.00
Open 26.00
Bid 21.95
Ask 26.21
Day Low-High 26.00-26.13
52wk Low-High 21.35-27.16
Volume 1,122
NAV (month end) 25.51
Premium (+)/Discount (-) (month end)+0.49

Zacks Premium Research for FTXH

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

Hold 3
ETF Risk

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

NA
ETF Snapshot

ETF Expense Ratio

Expense Ratio 0.60%
Dividend (Yield) $0.23 (0.89%)
Issuer FIRST TRUST ADVISORS

Benchmark for FTXH

NASDAQ US SMART PHARMACEUTICALS INDEX

The Nasdaq US Smart Pharmaceuticals Index is a modified factor weighted index, designed to provide exposure to US companies within the pharmaceuticals industry.

Fund Summary for FTXH

FIRST TRUST NASDAQ PHARMACEUTICALS ETF

The First Trust Nasdaq Pharmaceuticals ETF seeks investment results that correspond generally to the price and yield, before fees and expenses, of the Nasdaq US Smart Pharmaceuticals Index.